Trial intelligence / Profile preview

Dutasteride in Korean Men with Androgenetic Alopecia

NCT00441116Phase 3Completed

Sponsor
GSK
Start
Dec 2006
Primary completion
Jan 2008
Modality
Small Molecules
01

Overview

A Phase 3 trial of dutasteride in androgenetic alopecia (AGA), sponsored by GSK. Started Dec 2006; status: completed.

02

Drugs

dutasteride
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on NCT00441116.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00441116.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call